期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Research on Active Safety Methodologies for Intelligent Railway Systems
1
作者 Yong Qin Zhiwei Cao +6 位作者 Yongfu Sun Linlin Kou Xuejun Zhao Yunpeng Wu qinghong liu Mingming Wang Limin Jia 《Engineering》 SCIE EI CAS CSCD 2023年第8期266-279,共14页
Safety is essential when building a strong transportation system.As a key development direction in the global railway system,the intelligent railway has safety at its core,making safety a top priority while pursuing t... Safety is essential when building a strong transportation system.As a key development direction in the global railway system,the intelligent railway has safety at its core,making safety a top priority while pursuing the goals of efficiency,convenience,economy,and environmental friendliness.This paper describes the state of the art and proposes a system architecture for intelligent railway systems.It also focuses on the development of railway safety technology at home and abroad,and proposes the active safety method and technology system based on advanced theoretical methods such as the in-depth integration of cyber–physical systems(CPS),data-driven models,and intelligent computing.Finally,several typical applications are demonstrated to verify the advancement and feasibility of active safety technology in intelligent railway systems. 展开更多
关键词 Intelligent railway system Active safety methodology Prognostics and health management Intelligent surrounding perception Operation and maintenance risk control
下载PDF
A novel lectin from mushroom Phellodon melaleucus displays hemagglutination activity,and antitumor activity in a B16 melanoma mouse model
2
作者 Yuanhui Li Peng Wang +1 位作者 Zejun Zhang qinghong liu 《Food Science and Human Wellness》 SCIE CSCD 2023年第5期1885-1892,共8页
A novel lectin(termed PML)was purified from fruiting bodies of the edible mushroom Phellodon melaleucus(division Basidiomycota)by ion exchange,hydrophobic interaction,and gel filtration chromatographies,with overall t... A novel lectin(termed PML)was purified from fruiting bodies of the edible mushroom Phellodon melaleucus(division Basidiomycota)by ion exchange,hydrophobic interaction,and gel filtration chromatographies,with overall titer recovery~60%and 20-fold purification.PML displayed hemagglutination activity 13319 units/mg toward rabbit erythrocytes.SDS-PAGE and gel filtration analyses revealed that PML is a homodimeric lectin with a molecular weight of 28.8 kDa.PML hemagglutination activity was not inhibited by various simple sugars or their derivatives,but was enhanced by cations Ca^(2+),Mg^(2+),Zn^(2+),and Cu^(2+).The activity was stable in pH range 6–9 and in the temperature range 20–60°C.Circular dichroism(CD)spectroscopic analysis showed that PML was composed primarily ofβ-sheets with lowα-helix content.In a B16 melanoma mouse model,PML treatment significantly inhibited tumor growth,and increased cytokine IL-10 content.Our findings suggest that PML is a potential anticancer therapeutic agent. 展开更多
关键词 Phellodon melaleucus LECTIN Hemagglutination activity Cytokine IL-10 Antitumor activity
下载PDF
不同剂量瑞舒伐他汀对冠心病介入治疗患者血脂的影响分析 被引量:3
3
作者 王贵强 龚大彬 +1 位作者 刘庆虹 李敬松 《心血管外科杂志(电子版)》 2019年第2期94-96,共3页
目的研究分析冠心病介入治疗术后不同瑞舒伐他汀剂量对血脂的影响。方法随机选取2017年4月-2018年4月本院收治的120例行介入治疗的冠心病患者作为研究的对象。根据随机原则分为甲、乙、丙三组,每组40例,给予甲组患者实施常规治疗,乙、... 目的研究分析冠心病介入治疗术后不同瑞舒伐他汀剂量对血脂的影响。方法随机选取2017年4月-2018年4月本院收治的120例行介入治疗的冠心病患者作为研究的对象。根据随机原则分为甲、乙、丙三组,每组40例,给予甲组患者实施常规治疗,乙、丙两组分别联合瑞舒伐他汀5 mg/d、10 mg/d进行治疗,观察介入治疗术后不同瑞舒伐他汀剂量对血脂影响及安全性。结果治疗后,乙、丙两组患者的TC、LDL-C治疗效果均优于甲组及治疗前,差异有统计学意义(P<0.05)。三组患者的TG、HDL-C水平与治疗前相比无明显变化,差异无统计学意义(P>0.05)。乙、丙组两组患者缺血事件的发生率均低于甲组,差异有统计学意义(P<0.05)。乙组患者不良反应发生率高于甲组,比较差异无统计学意义(P>0.05);丙组不良反应发生率均高于甲组,差异有统计学意义(P<0.05)。结论应用瑞舒伐他汀对行介入治疗后的冠心病患者进行治疗,可有效改善患者的TC、LDL-C水平,降低缺血事件的发生率;随着瑞舒伐他汀剂量的增加,对患者血脂变化的影响也越大,同时也增加了不良反应的发生风险。 展开更多
关键词 冠心病 瑞舒伐他汀 血脂
下载PDF
Antioxidative and hepatoprotective activities of a novel polysaccharide (LSAP) from Lepista sordida mycelia 被引量:2
4
作者 Yingyin Xu Yuanhui Li +3 位作者 Yuxiao Lu Xiaobin Feng Guoting Tian qinghong liu 《Food Science and Human Wellness》 SCIE 2021年第4期536-544,共9页
A novel alkali-soluble polysaccharide from Lepista sordida(LSAP)mycelia with antioxidative and hepatoprotective activities was characterized.The weight-average molecular weight and number-average molecular weight of L... A novel alkali-soluble polysaccharide from Lepista sordida(LSAP)mycelia with antioxidative and hepatoprotective activities was characterized.The weight-average molecular weight and number-average molecular weight of LSAP were 1.442×10^(3) and 6.05×10^(2) kDa,respectively.LSAP was consisted of glucose(57.9%),xylose(31.8%),and small amounts of rhamnose,arabinose,galactose,glucuronic acid,and galacturonic acid(1.2%–3.1%).The FT-IR and 2D NMR confi rmed that LSAP was composed of Xylp,Araf,4-O-Me-α-D-GlcpA,(1→4)-linkedβ-D-Glcp,and(1→4)-α-D-GalA,andβ-glycosidic linkages between these sugar units.LSAP displayed notable effects on 1,1-dephenyl-2-picryhydrazyl(DPPH)radical scavenging,hydrogen peroxide scavenging,lipid peroxidation inhibitory ability,reducing power and Fe^(2+)chelating property.These biological effects were further verifi ed by suppressing CCl_(4)-induced oxidative liver damage in mice at doses of 100 and 200 mg/kg.Administration of LSAP in mice prior to CCl_(4) signifi cantly prevented the CCl_(4)-induced elevation in serum alanine aminotransferase,aspartate aminotransferase,and hepatic malondialdehyde.Mice treated with LSAP demonstrated to increase activities in superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)in the liver.We also found out that LSAP prevented CCl_(4)-induced oxidative liver histological alteration.LSAP may exert hepatoprotective effects against CCl_(4)-induced damage through antioxidant mechanisms in model mice. 展开更多
关键词 Lepista sordida POLYSACCHARIDE Antioxidant activity Hepatoprotective effects
下载PDF
Improvement of Clinical Symptoms and Gut Microbiome After Fecal Microbiota Transplantation:A Case Study of a 106-Year-Old Man with MODS
5
作者 Jingyun Fang Jiayu Yin +8 位作者 qinghong liu Xiangyi Yang Xuesong He Shengzhou Wang Min Fan Mohammed Alnaggar Jingsu Wang Zhaoqun Deng Yuanfei liu 《Proceedings of Anticancer Research》 2022年第1期1-5,共5页
Fecal microbiota transplantation(FMT)has been used in a wide variety of diseases.Many researchers hypothesize that the dysbiosis of intestinal microbiota plays an important role in the development of gut-derived infec... Fecal microbiota transplantation(FMT)has been used in a wide variety of diseases.Many researchers hypothesize that the dysbiosis of intestinal microbiota plays an important role in the development of gut-derived infections;thus,FMT is a potential therapeutic target against multiple organ dysfunction syndrome(MODS).A 106-year-old male patient was initially diagnosed with cerebral infarction and pulmonary infection.During the course of hospitalization,the patient developed MODS.The patient received a single nasogastric infusion of sterile-filtered,pathogen-free feces from a healthy donor.Fecal samples were collected every two days post-infusion to monitor changes in the microbiota composition in response to treatment.After FMT,MODS and severe diarrhea were alleviated;the patient’s fecal microbiome diversity resembled that of the healthy donor’s fecal microbiome;moreover,his clinical symptoms improved remarkably with the changes in fecal microbiome.Additionally,no observable side effects were noted during FMT treatment.These findings warrant further investigation of FMT as a putative new therapy for treating microbiota-related diseases,such as MODS. 展开更多
关键词 MODS Fecal microbiota transplantation Therapeutic efficacy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部